NASDAQ:ITOS
iTeos Therapeutics, Inc.
- Stock
Last Close
16.71
26/07 20:00
Market Cap
550.87M
Beta: 1.33
Volume Today
169.95K
Avg: 246.75K
PE Ratio
−5.98
PFCF: −3.10
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | -162.50K - | -5.21M 3,103.38% | -5.04M 3.12% | ||||
average payables | 1.27M - | 2.10M 65.29% | 4.09M 94.55% | 6.40M 56.74% | 9.48M 48.00% | ||
average receivables | 3.24M - | 2.83M 12.84% | 6.21M 119.58% | 7.26M 17.00% | 3.47M 52.20% | ||
book value per share | 2.00 - | 1.58 21.13% | 21.43 1,255.81% | 15.71 26.68% | 18.66 18.74% | 0.02 99.91% | |
capex per share | -0.03 - | -0.07 141.73% | -0.02 67.54% | -0.03 42.20% | -0.03 21.40% | -0.00 99.69% | |
capex to depreciation | -0.45 - | -1.18 163.68% | -0.67 43.61% | -1.96 194.33% | -1.17 40.36% | -3.30 182.75% | |
capex to operating cash flow | 0.01 - | 0.03 163.23% | 0.01 54.61% | -0.00 116.28% | 0.01 466.53% | 0.03 238.87% | |
capex to revenue | -0.00 - | -0.00 2.32% | -0.24 6,619.00% | ||||
cash per share | 2.93 - | 2.00 31.54% | 22.30 1,012.71% | 24.12 8.14% | 17.25 28.49% | 0.01 99.91% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | 12.80 - | 3.32 74.05% | 130.64 3,833.88% | ||||
debt to assets | 0.07 - | 0.14 90.33% | 0.01 - | 0.01 2.53% | 0.01 46.61% | ||
debt to equity | 0.13 - | 0.27 105.24% | 0.01 - | 0.01 27.08% | 0.01 49.49% | ||
dividend yield | |||||||
earnings yield | -0.13 - | -0.12 5.78% | -0.07 37.29% | 0.13 275.62% | 0.14 6.29% | -0.00 100.21% | |
enterprise value | 121.09M - | 168.97M 39.54% | 173.69M 2.80% | 794.85M 357.63% | 414.20M 47.89% | 391.37B 94,386.83% | |
enterprise value over ebitda | -6.93 - | -7.78 12.24% | -4.48 42.40% | 3.11 169.39% | 3.18 2.19% | -2.59K 81,635.78% | |
ev to operating cash flow | -6.34 - | -7.30 15.13% | -6.90 5.50% | 1.55 122.45% | -3.73 340.48% | -3.77K 101,159.43% | |
ev to sales | 2.31 - | 1.55 32.87% | 31.07K 2,007,641.91% | ||||
free cash flow per share | -2.57 - | -2.41 6.42% | -1.69 29.68% | 14.55 959.50% | -3.15 121.67% | -0.00 99.91% | |
free cash flow yield | -0.14 - | -0.13 6.42% | -0.05 60.39% | 0.31 724.32% | -0.16 151.67% | -0.00 99.83% | |
graham net net | 1.40 - | 0.89 36.68% | 20.89 2,255.98% | 14.80 29.16% | 14.72 0.54% | 0.01 99.92% | |
graham number | 10.41 - | 8.98 13.80% | 34.87 288.53% | 46.43 33.14% | 33.78 27.24% | 0.03 99.90% | |
income quality | 1.06 - | 1.03 2.54% | 0.66 35.78% | 2.39 261.36% | -1.15 148.10% | 0.92 180.07% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -325.77 - | -6.60 - | |||||
interest debt per share | 0.27 - | 0.43 56.69% | 0.15 - | -0.41 368.21% | 0.00 100.04% | ||
inventory turnover | |||||||
invested capital | 0.13 - | 0.27 105.24% | 0.01 - | 0.01 27.08% | 0.01 49.49% | ||
market cap | 143.08M - | 188.83M 31.98% | 510.01M 170.09% | 1.64B 221.18% | 694.33M 57.61% | 391.61B 56,301.13% | |
net current asset value | 11.33M - | 11.00M 2.94% | 318.18M 2,792.31% | 542.82M 70.60% | 536.64M 1.14% | 458.29M 14.60% | |
net debt to ebitda | 1.26 - | 0.91 27.31% | 8.67 848.48% | -3.30 138.02% | -2.15 34.85% | 1.62 175.51% | |
net income per share | -2.40 - | -2.27 5.78% | -2.52 11.34% | 6.10 341.77% | 2.72 55.41% | -0.00 100.12% | |
operating cash flow per share | -2.54 - | -2.33 8.17% | -1.67 28.50% | 14.59 973.67% | -3.13 121.44% | -0.00 99.91% | |
payables turnover | |||||||
receivables turnover | 28.52 - | 109.91 285.41% | 2.79 97.46% | ||||
research and ddevelopement to revenue | 0.17 - | 0.36 111.26% | 9.00 2,372.81% | ||||
return on tangible assets | -0.66 - | -0.73 10.79% | -0.11 84.89% | 0.24 319.67% | 0.13 47.20% | -0.17 231.80% | |
revenue per share | 9.80 - | 7.53 23.18% | 0.00 100.00% | ||||
roe | -1.20 - | -1.43 19.46% | -0.12 91.79% | 0.39 429.76% | 0.15 62.45% | -0.20 234.39% | |
roic | -1.26 - | -1.41 12.11% | -0.14 90.12% | 0.36 360.10% | 0.12 66.43% | -0.27 317.80% | |
sales general and administrative to revenue | 0.12 - | 0.16 39.77% | 4.00 2,336.71% | ||||
shareholders equity per share | 2.00 - | 1.58 21.13% | 21.43 1,255.81% | 15.71 26.68% | 18.66 18.74% | 0.02 99.91% | |
stock based compensation to revenue | 0.04 - | 0.08 101.36% | 2.15 2,562.99% | ||||
tangible asset value | 15.05M - | 15.67M 4.09% | 323.20M 1,962.65% | 552.82M 71.05% | 663.33M 19.99% | 575.23M 13.28% | |
tangible book value per share | 2.00 - | 1.58 21.13% | 21.43 1,255.81% | 15.71 26.68% | 18.66 18.74% | 0.02 99.91% | |
working capital | 18.66M - | 12.88M 30.97% | 324.55M 2,419.77% | 570.59M 75.81% | 586.30M 2.75% | 510.64M 12.90% |
All numbers in USD (except ratios and percentages)